Skip to main content
Top
Published in: Journal of Orthopaedic Surgery and Research 1/2019

Open Access 01-12-2019 | Tranexamic Acid | Research article

Effects of tranexamic acid on the recovery of osteochondral defects treated by microfracture and acellular matrix scaffold: an experimental study

Authors: Erdem Degirmenci, Kutay Engin Ozturan, Abdullah Alper Sahin, Fahri Yilmaz, Yasin Emre Kaya

Published in: Journal of Orthopaedic Surgery and Research | Issue 1/2019

Login to get access

Abstract

Background

Microfracture and scaffold application in the treatment of osteochondral defects is still one of the most frequently used methods in the clinic. The most important step in this treatment method is the stabilization of fibrin clot. Tranexamic acid (TA) is an antifibrinolytic agent commonly used in orthopedic surgery in recent years. This study evaluated the effect of local TA application on healing of experimentally induced osteochondral defects on rabbits.

Methods

This paper contains an animal in vivo data and histological outcomes on the effect of TA. Eighteen New Zealand white rabbits were treated unilaterally and cylindrical defects having a width of 4 mm and depth of 5 mm were created in the weight-bearing surfaces of the medial and lateral condyles of the right femur. They were divided into two groups, as group 1 study and group 2 control groups, respectively. One milliliter (ml) of TA was injected into the knee joints of the subjects in group 1. All animals were sacrificed for the extraction of the femur condyles for histologic study at the fourth and eighth weeks after surgery. Histological evaluations were performed by Brittberg and O’Driscoll scores to all samples. Data were organized in a Standard Statistical Package System v.22 software package (SPSS/PC Inc., Chicago, IL.) and reported as mean and median (min-max). Repeated measures ANOVA test was used to compare groups and condyle effects together for each week. p values below 0.05 were considered as statistically significant.

Results

Samples were taken in the fourth and eighth weeks. The regularity of the surface in group 1 was smoother, and the tissue stability was more robust. Mean Brittberg scores in both weeks were statistically higher in group 1 when compared with group 2. In the microscopic evaluation, it was observed that the regeneration of subchondral and cartilage tissues were more rapid and organized in group 1, and the mean O’ Driscoll scores in both weeks were statistically higher in group 1.

Conclusions

Application of TA improves the healing time and tissue stability in osteochondral defects which are implanted a-cellular scaffold after microfracture and should be applicable to humans for the treatment of osteochondral defects.
Appendix
Available only for authorised users
Literature
1.
go back to reference Messner K, Maletius W. The long-term prognosis for severe damage to weight-bearing cartilage in the knee: a 14-year clinical and radiographic follow-up in 28 young athletes. Acta Orthop Scand. 1996;67:165–8.CrossRef Messner K, Maletius W. The long-term prognosis for severe damage to weight-bearing cartilage in the knee: a 14-year clinical and radiographic follow-up in 28 young athletes. Acta Orthop Scand. 1996;67:165–8.CrossRef
2.
go back to reference Buckwalter JA, Lane NE. Athletics and osteoarthritis. Am J Sports Med. 1997;25:873–81.CrossRef Buckwalter JA, Lane NE. Athletics and osteoarthritis. Am J Sports Med. 1997;25:873–81.CrossRef
3.
go back to reference Dowthwaite GP, Bishop JC, Redman SN, Khan IM, Rooney P, Evans DJ, et al. The surface of articular cartilage contains a progenitor cell population. J Cell Sci. 2004;117:889–97.CrossRef Dowthwaite GP, Bishop JC, Redman SN, Khan IM, Rooney P, Evans DJ, et al. The surface of articular cartilage contains a progenitor cell population. J Cell Sci. 2004;117:889–97.CrossRef
4.
go back to reference Steinwachs MR, Guggi T, Kreuz PC. Marrow stimulation techniques. Injury. 2008;39:26–31.CrossRef Steinwachs MR, Guggi T, Kreuz PC. Marrow stimulation techniques. Injury. 2008;39:26–31.CrossRef
5.
go back to reference Rastrelli A, Beccaro M, Biviano F. Hyaluronic acid esters, a new class of semisynthetic biopolymers: chemical and physico-chemical characterization. Clin Implant Mater. 1990;9:199–205. Rastrelli A, Beccaro M, Biviano F. Hyaluronic acid esters, a new class of semisynthetic biopolymers: chemical and physico-chemical characterization. Clin Implant Mater. 1990;9:199–205.
6.
go back to reference Benedetti L, Cortivo R, Berti T, Pea F, Mazzo M, Moras M, Abatangelo G. Biocompatibility and biodegradation of diferent hyaluronan derivative (HYAFF) implanted in rats. Biomaterials. 1993;14(15):1135–9.CrossRef Benedetti L, Cortivo R, Berti T, Pea F, Mazzo M, Moras M, Abatangelo G. Biocompatibility and biodegradation of diferent hyaluronan derivative (HYAFF) implanted in rats. Biomaterials. 1993;14(15):1135–9.CrossRef
7.
go back to reference Cook JL, Stannard JP, Stoker AM, Bozynski CC, Kuroki K, Cook CR, Pfeiffer FM. Importance of donor chondrocyte viability for osteochondral allografts. Am J Sports Med. 2016;44:1260–8.CrossRef Cook JL, Stannard JP, Stoker AM, Bozynski CC, Kuroki K, Cook CR, Pfeiffer FM. Importance of donor chondrocyte viability for osteochondral allografts. Am J Sports Med. 2016;44:1260–8.CrossRef
8.
go back to reference Wang CC, Yang KC, Lin KH, Liu HC, Lin FH. A highly organized three-dimensional alginate scaffold for cartilage tissue engineering prepared by microfluidic technology. Biomaterials. 2011;32:7118–26.CrossRef Wang CC, Yang KC, Lin KH, Liu HC, Lin FH. A highly organized three-dimensional alginate scaffold for cartilage tissue engineering prepared by microfluidic technology. Biomaterials. 2011;32:7118–26.CrossRef
9.
go back to reference Solchaga LA, Temenoff JS, Gao J, Mikos AG, Caplan AI, Goldberg VM. Repair of osteochondral defects with hyaluronan and polyester-based scaffolds. Osteoarthr Cartil. 2005;13:297–309.CrossRef Solchaga LA, Temenoff JS, Gao J, Mikos AG, Caplan AI, Goldberg VM. Repair of osteochondral defects with hyaluronan and polyester-based scaffolds. Osteoarthr Cartil. 2005;13:297–309.CrossRef
10.
go back to reference Albrecht C, Tichy B, Nürnberger S, Hosiner S, Zak L, Aldrian S, Marlovits S. Gene expression and cell differentiation in matrix-associated chondrocyte transplantation grafts: a comparative study. Osteoarthr Cartil. 2011;19:1219–27.CrossRef Albrecht C, Tichy B, Nürnberger S, Hosiner S, Zak L, Aldrian S, Marlovits S. Gene expression and cell differentiation in matrix-associated chondrocyte transplantation grafts: a comparative study. Osteoarthr Cartil. 2011;19:1219–27.CrossRef
11.
go back to reference Siclari A, Mascaro G, Gentili C, Cancedda R, Boux E. A cell-free scaffold-based cartilage repair provides improved function hyaline-like repair at one year. Clin Orthop Relat Res. 2012;470:910–9.CrossRef Siclari A, Mascaro G, Gentili C, Cancedda R, Boux E. A cell-free scaffold-based cartilage repair provides improved function hyaline-like repair at one year. Clin Orthop Relat Res. 2012;470:910–9.CrossRef
12.
go back to reference Erggelet C, Neumann K, Endres M, et al. Regeneration of ovine articular cartilage defects by cell-free polymer-based implants. Biomaterials. 2007;28:5570–80.CrossRef Erggelet C, Neumann K, Endres M, et al. Regeneration of ovine articular cartilage defects by cell-free polymer-based implants. Biomaterials. 2007;28:5570–80.CrossRef
13.
go back to reference Bauer C, Berger M, Baumgartner RR, et al. A novel cross-linked hyaluronic acid porous scaffold for cartilage repair: an in vitro study with osteoarthritic chondrocytes. Cartilage. 2016;7:265–73.CrossRef Bauer C, Berger M, Baumgartner RR, et al. A novel cross-linked hyaluronic acid porous scaffold for cartilage repair: an in vitro study with osteoarthritic chondrocytes. Cartilage. 2016;7:265–73.CrossRef
14.
go back to reference Cholewinski E, Dietrich M, Flanagan TC, Schmitz-Rode T, Jockenhoevel S. Tranexamic acid—an alternative to aprotinin in fibrin-based cardiovascular tissue engineering. Tissue Eng. 2009;15:1–11. Cholewinski E, Dietrich M, Flanagan TC, Schmitz-Rode T, Jockenhoevel S. Tranexamic acid—an alternative to aprotinin in fibrin-based cardiovascular tissue engineering. Tissue Eng. 2009;15:1–11.
15.
go back to reference Kuo FC, Lin PY, Wang JW, Lin PC, Lee MS, Chen AF. Intravenous tranexamic acid use in revision total joint arthroplasty: a meta-analysis. Drug Des Devel Ther. 2018;12:3163–70.CrossRef Kuo FC, Lin PY, Wang JW, Lin PC, Lee MS, Chen AF. Intravenous tranexamic acid use in revision total joint arthroplasty: a meta-analysis. Drug Des Devel Ther. 2018;12:3163–70.CrossRef
16.
go back to reference Marmotti A, Mattia S, Mangiavini L, Bonasia DE, Bruzzone M, Dettoni F. et.al. Tranexamic acid effects on cartilage and synovial tissue: an in vitro study for a possible safe intra-articular use. J Biol Regul Homeost Agents. 2016;30:33–40.PubMed Marmotti A, Mattia S, Mangiavini L, Bonasia DE, Bruzzone M, Dettoni F. et.al. Tranexamic acid effects on cartilage and synovial tissue: an in vitro study for a possible safe intra-articular use. J Biol Regul Homeost Agents. 2016;30:33–40.PubMed
17.
go back to reference Chu CR, Szczodry M, Bruno S. Animal models for cartilage regeneration and repair. Tissue Eng Part B Rev. 2010;16:105–15.CrossRef Chu CR, Szczodry M, Bruno S. Animal models for cartilage regeneration and repair. Tissue Eng Part B Rev. 2010;16:105–15.CrossRef
19.
go back to reference Ambra LF, de Girolamo L, Niu W, Phan A, Spector M, Gomoll AH. No effect of topical application of tranexamic acid on articular cartilage. Knee Surg Sports Traumatol Arthrosc. 2017;Nov 8:4746–9. Ambra LF, de Girolamo L, Niu W, Phan A, Spector M, Gomoll AH. No effect of topical application of tranexamic acid on articular cartilage. Knee Surg Sports Traumatol Arthrosc. 2017;Nov 8:4746–9.
20.
go back to reference Sitek P, Wysocka-Wycisk A, Kępski F, Król D, Bursig H, Dyląg S. PRP-fibrinogen gel-like chondrocyte carrier stabilized by TXA-preliminary study. Cell Tissue Bank. 2013;14:133–40.CrossRef Sitek P, Wysocka-Wycisk A, Kępski F, Król D, Bursig H, Dyląg S. PRP-fibrinogen gel-like chondrocyte carrier stabilized by TXA-preliminary study. Cell Tissue Bank. 2013;14:133–40.CrossRef
21.
go back to reference Verstraete M. Clinical application of inhibitors of fibrinolysis. Drugs. 1985;3:236–61.CrossRef Verstraete M. Clinical application of inhibitors of fibrinolysis. Drugs. 1985;3:236–61.CrossRef
22.
go back to reference Buda R, Vannini F, Cavallo M, Baldassarri M, Luciani D, Mazzotti A, et al. One-step arthroscopic technique for the treatment of osteochondral lesions of the knee with bone-marrow-derived cells: three years results. Musculoskelet Surg. 2013;97(2):145–51. Buda R, Vannini F, Cavallo M, Baldassarri M, Luciani D, Mazzotti A, et al. One-step arthroscopic technique for the treatment of osteochondral lesions of the knee with bone-marrow-derived cells: three years results. Musculoskelet Surg. 2013;97(2):145–51.
23.
go back to reference O’Driscoll SW, Keeley FW, Salter RB. Durability of regenerated articular cartilage produced by free autogenous periosteal grafts in major full-thickness defects in joint surfaces under the influence of continuous passive motion. A follow-up report at one year. J Bone Joint Surg. 1988;70A:595–606.CrossRef O’Driscoll SW, Keeley FW, Salter RB. Durability of regenerated articular cartilage produced by free autogenous periosteal grafts in major full-thickness defects in joint surfaces under the influence of continuous passive motion. A follow-up report at one year. J Bone Joint Surg. 1988;70A:595–606.CrossRef
24.
go back to reference Gille J, Behrens P, Volpi P, de Girolamo L, Reiss E, Zoch W, Anders S. Outcome of autologous matrix induced chondrogenesis (AMIC) in cartilage knee surgery: data of the AMIC Registry. Arch Orthop Trauma Surg. 2013;133:87–93.CrossRef Gille J, Behrens P, Volpi P, de Girolamo L, Reiss E, Zoch W, Anders S. Outcome of autologous matrix induced chondrogenesis (AMIC) in cartilage knee surgery: data of the AMIC Registry. Arch Orthop Trauma Surg. 2013;133:87–93.CrossRef
25.
go back to reference Bark S, Piontek T, Behrens P, Mkalaluh S, Varoga D, Gille J. Enhanced microfracture techniques in cartilage knee surgery: fact or fiction? World J Orthop. 2014;5(4):444–9.CrossRef Bark S, Piontek T, Behrens P, Mkalaluh S, Varoga D, Gille J. Enhanced microfracture techniques in cartilage knee surgery: fact or fiction? World J Orthop. 2014;5(4):444–9.CrossRef
26.
go back to reference Gille J, Schuseil E, Wimmer J, Gellissen J, Schulz AP, Behrens P. Mid-term results of autologous matrix-induced chondrogenesis for treatment of focal cartilage defects in the knee. Knee Surg Sports Traumatol Arthrosc. 2010;18(11):1456–64.CrossRef Gille J, Schuseil E, Wimmer J, Gellissen J, Schulz AP, Behrens P. Mid-term results of autologous matrix-induced chondrogenesis for treatment of focal cartilage defects in the knee. Knee Surg Sports Traumatol Arthrosc. 2010;18(11):1456–64.CrossRef
27.
go back to reference Insall J. The Pridie debridement operation for osteoarthritis of the knee. Clin Orthop Relat Res. 1974;101:61–7. Insall J. The Pridie debridement operation for osteoarthritis of the knee. Clin Orthop Relat Res. 1974;101:61–7.
28.
go back to reference Steadman JR, Briggs KK, Rodrigo JJ, Kocher MS, Gill TJ, Rodkey WG. Outcomes of microfracture for traumatic chondral defects of the knee: Average 11-year follow-up. Arthroscopy. 2003;19(5):477–84.CrossRef Steadman JR, Briggs KK, Rodrigo JJ, Kocher MS, Gill TJ, Rodkey WG. Outcomes of microfracture for traumatic chondral defects of the knee: Average 11-year follow-up. Arthroscopy. 2003;19(5):477–84.CrossRef
29.
go back to reference Midhoefer K, Mc Adams T, Williams RJ, Kreuz PC, Mandelbaum BR. Clinical efficacy of microfracture technique for articuler cartilage repair in the knee: An evidence-based systematic analysis. Am J Sports Med. 2009;37:2053–63.CrossRef Midhoefer K, Mc Adams T, Williams RJ, Kreuz PC, Mandelbaum BR. Clinical efficacy of microfracture technique for articuler cartilage repair in the knee: An evidence-based systematic analysis. Am J Sports Med. 2009;37:2053–63.CrossRef
30.
go back to reference Gudas R, Kalesinskas RJ, Kimtys V, Stankevicius E, Toliusis V, Bernotavicius G, Smailys A. A prospective randomized clinical study of mosaic osteochondral autologous transplantation versus microfracture for the treatment of osteochondral defects in the knee joint in young athletes. Arthroscopy. 2005;21:1066–75.CrossRef Gudas R, Kalesinskas RJ, Kimtys V, Stankevicius E, Toliusis V, Bernotavicius G, Smailys A. A prospective randomized clinical study of mosaic osteochondral autologous transplantation versus microfracture for the treatment of osteochondral defects in the knee joint in young athletes. Arthroscopy. 2005;21:1066–75.CrossRef
31.
go back to reference Erggelet C, Endres M, Neumann K, Morawietz L, Ringe J, Haberstroh K, et al. Formation of cartilage repair tissue in articular cartilage defects pretreated with microfracture and covered with cell-free polymer-based implants. Inc J Orthop Res. 2009;27:1353–60.CrossRef Erggelet C, Endres M, Neumann K, Morawietz L, Ringe J, Haberstroh K, et al. Formation of cartilage repair tissue in articular cartilage defects pretreated with microfracture and covered with cell-free polymer-based implants. Inc J Orthop Res. 2009;27:1353–60.CrossRef
32.
go back to reference Schuttler KF, Schenker H, Theisen C, Schofer MD, Getgood A, Roessler PP, et al. Use of cell-free collagen type I matrix implants for the treatment of small cartilage defects in the knee: clinical and magnetic resonance imaging evaluation. Knee Surg Sports Traumatol Arthrosc. 2014;22:1270–6.CrossRef Schuttler KF, Schenker H, Theisen C, Schofer MD, Getgood A, Roessler PP, et al. Use of cell-free collagen type I matrix implants for the treatment of small cartilage defects in the knee: clinical and magnetic resonance imaging evaluation. Knee Surg Sports Traumatol Arthrosc. 2014;22:1270–6.CrossRef
33.
go back to reference Sofu H, Kockara N, Oner A, Camurcu Y, Issın A, Sahin V. Results of hyaluronic acid based cell-free scaffold application in combination with microfracture for the treatment of osteochondral lesions of the knee: 2-year comparative study arthroscopy. J Arthroscopic and Related Surg. 2017;33:209–16.CrossRef Sofu H, Kockara N, Oner A, Camurcu Y, Issın A, Sahin V. Results of hyaluronic acid based cell-free scaffold application in combination with microfracture for the treatment of osteochondral lesions of the knee: 2-year comparative study arthroscopy. J Arthroscopic and Related Surg. 2017;33:209–16.CrossRef
34.
go back to reference Efe T, Theisen C, Fuchs-Winkelmann S, Stein T, Getgood A, Rominger MB. Cell-free collagen type 1 matrix for repair of cartilage defects- clinical and magnetic resonance imaging result. Knee Surg Sport Trumatol Arthtrosc. 2012;20(10):1915–22. Efe T, Theisen C, Fuchs-Winkelmann S, Stein T, Getgood A, Rominger MB. Cell-free collagen type 1 matrix for repair of cartilage defects- clinical and magnetic resonance imaging result. Knee Surg Sport Trumatol Arthtrosc. 2012;20(10):1915–22.
35.
go back to reference Goyal D, Keyhani S, Lee EH, Hui JH. Evidence-based status of microfracture technique: a systematic review of level 1 and 2 studies. Arthroscopy. 2013;29(9):1579–88.CrossRef Goyal D, Keyhani S, Lee EH, Hui JH. Evidence-based status of microfracture technique: a systematic review of level 1 and 2 studies. Arthroscopy. 2013;29(9):1579–88.CrossRef
36.
go back to reference Knutsen G, Drogset JO, Engebretsen L, Grontvedt T, Isaksen V, Ludvigsen TC, et al. A randomized trial comparing autologous chondrocyte implantation with microfracture. Findings at five years. J Bone Joint Surg Am. 2007;89:2105–12.PubMed Knutsen G, Drogset JO, Engebretsen L, Grontvedt T, Isaksen V, Ludvigsen TC, et al. A randomized trial comparing autologous chondrocyte implantation with microfracture. Findings at five years. J Bone Joint Surg Am. 2007;89:2105–12.PubMed
37.
go back to reference Knutsen G, Drogset JO, Engebretsen L, Isaksen V, Ludvigsen TC, et al. A randomized multicenter trial comparing autologous chondrocyte implantation with microfracture long-term follow-up at 14 to 15 years. J Bone Joint Surg Am. 2016;98:1332–9.CrossRef Knutsen G, Drogset JO, Engebretsen L, Isaksen V, Ludvigsen TC, et al. A randomized multicenter trial comparing autologous chondrocyte implantation with microfracture long-term follow-up at 14 to 15 years. J Bone Joint Surg Am. 2016;98:1332–9.CrossRef
38.
go back to reference Saris D, Price A, Widuchowski W, Bertrand-Marchand M, Caron J, Drogset JO, et al. Summit Study Group. Matrix-applied characterized autologous cultured chondrocytes versus microfracture: two-year follow-up of a prospective randomized trial. Am J Sports Med. 2014;42(6):1384–94.CrossRef Saris D, Price A, Widuchowski W, Bertrand-Marchand M, Caron J, Drogset JO, et al. Summit Study Group. Matrix-applied characterized autologous cultured chondrocytes versus microfracture: two-year follow-up of a prospective randomized trial. Am J Sports Med. 2014;42(6):1384–94.CrossRef
39.
go back to reference Fillingham YA, Ramkumar DB, Jevsevar DS, Yates AJ, Shores P, Mullen K, et al. The efficacy of tranexamic acid in total knee arthroplasty: a network meta-analysis. J Arthroplasty. 2018;33(10):3090–8.CrossRef Fillingham YA, Ramkumar DB, Jevsevar DS, Yates AJ, Shores P, Mullen K, et al. The efficacy of tranexamic acid in total knee arthroplasty: a network meta-analysis. J Arthroplasty. 2018;33(10):3090–8.CrossRef
40.
go back to reference Gianakos AL, Hurley ET, Haring RS, Yoon RS, Liporace FA. Reduction of blood loss by tranexamic acid following total hip and knee arthroplasty: A meta-analysis. JBJS Rev. 2018;6:5. Gianakos AL, Hurley ET, Haring RS, Yoon RS, Liporace FA. Reduction of blood loss by tranexamic acid following total hip and knee arthroplasty: A meta-analysis. JBJS Rev. 2018;6:5.
41.
go back to reference Parker JD, Lim KS, Kieser DC, Woodfield TBF, Hooper GJ. Is tranexamic acid toxic to articular cartilage when administered topically? Bone Joint J. 2018;100-B(3):404–12.CrossRef Parker JD, Lim KS, Kieser DC, Woodfield TBF, Hooper GJ. Is tranexamic acid toxic to articular cartilage when administered topically? Bone Joint J. 2018;100-B(3):404–12.CrossRef
42.
go back to reference Tuttle JR, Feltman PR, Ritterman SA, Ehrlich MG. Effects of tranexamic acid cytotoxicity on in vitro chondrocytes. Am J Orthop. 2015;44:497–502. Tuttle JR, Feltman PR, Ritterman SA, Ehrlich MG. Effects of tranexamic acid cytotoxicity on in vitro chondrocytes. Am J Orthop. 2015;44:497–502.
Metadata
Title
Effects of tranexamic acid on the recovery of osteochondral defects treated by microfracture and acellular matrix scaffold: an experimental study
Authors
Erdem Degirmenci
Kutay Engin Ozturan
Abdullah Alper Sahin
Fahri Yilmaz
Yasin Emre Kaya
Publication date
01-12-2019
Publisher
BioMed Central
Keyword
Tranexamic Acid
Published in
Journal of Orthopaedic Surgery and Research / Issue 1/2019
Electronic ISSN: 1749-799X
DOI
https://doi.org/10.1186/s13018-019-1144-7

Other articles of this Issue 1/2019

Journal of Orthopaedic Surgery and Research 1/2019 Go to the issue